OEP Pharma is a full-service, global pharmaceutical company. Leveraging its R&D capabilities and commercial infrastructure in Asia, OEP Pharma develops, manufactures, and commercializes branded and generic medicines.

OEP Pharma is the U.S. headquarters of OEP Group, a TWSE-listed pharmaceutical company founded in Taiwan in 1982. With a market cap of $200 million USD and 1000 employees worldwide, OEP has a 40-year track record as a distributor of choice in Taiwan and ASEAN countries. 

Today, OEP has a growing generics and specialty pharma product portfolio and pipeline, experienced salesforce in 10 countries, and distribution partners in North America. Its FDA-approved oral dosage facility, and injectables facility (FDA approval expected early 2021) specialize in complex formulations, including highly potent compounds, modified release products, and poorly soluble compounds.

OEP Pharma

Org chart

Teams

Offices